Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RORγt inverse agonists(RAR-related orphan receptor gamma 2 inverse agonists), TGR5 agonists(G-protein coupled bile acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | IT | 10 Sep 2024 |